News
On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study.
The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until ...
The GOP-led House Judiciary Committee is investigating Pfizer's COVID-19 vaccine development timeline. They are focusing on allegations that vaccine testing results were delayed until after the 2020 ...
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...
As healthcare systems worldwide shift toward personalized treatment, biopharmaceuticals are gaining momentum for their ability to target disease mechanisms at the molecular level. The rapid ...
Royalty Pharma plc (Nasdaq: RPRX) today announced that it has successfully closed the acquisition of its external manager, RP Management, LLC (“RP Management”). The acquisition received overwhelming ...
Allegations of Political Manipulation in Covid Vaccine Release Prompt House GOP Investigation** In a striking turn of events, the House GOP is launching an investigation into Pfizer's potential ...
Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...
Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | ...
Based on 13 Wall Street analysts offering 12 month price targets forGlaxoSmithKline PLC - Dist in the last 3 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results